Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionGeneos Wealth Management Inc.
Latest Disclosed Ownership240,927 shares
Latest Disclosed Value $ 672,186
Geneos Wealth Management Inc. reports 0.99% decrease in ownership of PHPN / Galectin Therapeutics Inc.

On May 4, 2026 - Geneos Wealth Management Inc. filed a 13F-HR form disclosing ownership of 240,927 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $539,676 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 243,327 shares of Galectin Therapeutics Inc.. This represents a change in shares of -0.99% during the quarter. The current value of the position is $452,943 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 240,927 -2,400 -0.99 672 -33.60 0.0156
2026-01-28 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 243,327 -116,848 -32.44 1,012 -33.73 0.0248
2025-10-22 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 360,175 -63,060 -14.90 1,527 71.00 0.0387
2025-08-18 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 423,235 0 0.00 893 73.06 0.0218
2025-05-21 2025-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 423,235 34,300 8.82 516 2.99 0.0173
2025-05-08 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 427,435 38,500 521 0.0132
2025-01-21 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 388,935 36,000 10.20 502 -48.35 0.0176
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 352,935 -40,790 -10.36 971 9.11 0.0370
2024-07-23 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 393,725 -15,125 -3.70 890 -9.01 0.0395
2024-05-03 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 408,850 -3,800 -0.92 977 42.84 0.0447
2024-01-26 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 412,650 -4,700 -1.13 685 -14.61 0.0338
2023-10-11 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 417,350 -4,300 -1.02 801 31.96 0.0413
2023-08-08 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 421,650 -5,750 -1.35 607 -32.33 0.0318
2023-04-25 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 427,400 -7,400 -1.70 898 82.69 0.0545
2023-01-31 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 434,800 -10,400 -2.34 491 -32.28 0.0298
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 445,200 -32,867 -6.87 725 15.81 0.0499
2022-07-22 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 478,067 3,300 0.70 626 -18.06 0.0309
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 474,767 -6,000 -1.25 764 -23.22 0.0328
2022-02-09 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 480,767 -10,600 -2.16 995 -46.71 0.0379
2021-11-09 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 491,367 -900 -0.18 1,867 19.68 0.0715
2021-07-08 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 492,267 -19,339 -3.78 1,560 -31.00 0.0608
2021-06-17 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 511,606 26,000 5.35 2,261 135.28 0.0631
2021-05-19 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 485,606 448,589 1,211.85 961 851.49 0.0386
2021-09-07 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 37,017 0 0.00 101 -6.48 0.0052
2021-09-07 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 37,017 -4,733 -11.34 108 35.00 0.0060
2021-09-07 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 41,750 -2,000 -4.57 80 -36.51 0.0054
2021-09-07 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 43,750 -400 -0.91 126 -21.25 0.0067
2021-09-07 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 44,150 -9,000 -16.93 160 -27.27 0.0096
2021-09-07 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 53,150 -2,500 -4.49 220 -22.54 0.0136
2021-09-07 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 55,650 -4,000 -6.71 284 26.79 0.0187
2021-09-07 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 59,650 0 0.00 224 -37.43 0.0166
2021-09-07 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 59,650 47,300 383.00 358 358.97 0.0238
2021-09-07 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 12,350 -29,040 -70.16 78 -60.20 0.0061
2021-09-07 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 41,390 -32,095 -43.68 196 -20.00 0.0171
2021-09-07 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 73,485 4,873 7.10 245 67.81 0.0219
2021-09-07 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 68,612 8,000 13.20 146 -2.01 0.0145
2021-09-07 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 60,612 4,000 7.07 149 14.62 0.0153
2021-09-07 2017-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 56,612 4,000 7.60 130 154.90 0.0135
2021-09-07 2016-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 52,612 1,800 3.54 51 -10.53 0.0067
2021-09-07 2016-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 50,812 0 0.00 57 -25.97 0.0077
2021-09-07 2016-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 50,812 0 0.00 77 5.48 0.0112
2021-09-07 2016-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 50,812 50,812 73 0.0112
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.